News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immutep.
RELATED STOCKHEAD STORIES
News
10 at 10: These ASX stocks have surprised their shareholders this morning
News
Last Orders: What you might have missed on the ASX today
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Wait, stocks actually fall too?
Health & Biotech
Immutep breast cancer trial results ‘highly encouraging’, shares jump 50pc
News
10 at 10: These ASX stocks are the best supported this morning
News
10 at 10: These ASX stocks are riding through the storms this morning
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
Health & Biotech
Immutep partners with LabCorp to develop immotherapy diagnostic
Health & Biotech
Czech hospital begins COVID study testing Immutep’s efti drug
News
Last Orders: What you might have missed today on the ASX
Experts
ScoPo’s Health Powerplays: The money keeps flowing for the ASX biotechs
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s dodging bullets today?
Health & Biotech
Immutep’s cancer-fighting drug candidate efti shows early promise
News
10 at 10: These ASX stocks have imposed their presence this morning
Health & Biotech